Wilmer Cutler Pickering Hale and Dorr advised MicroStrategy Incorporated in the offering, and Davis Polk & Wardwell advised Barclays Capital, Inc., as representatives of the initial...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale advised MicroStrategy Incorporated, and Davis Polk advised the Agents on the offering. MicroStrategy Incorporated (MicroStrategy) (Nasdaq: MSTR) announced the company’s new at-the-market...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised MicroStrategy Incorporated in the offering, and Davis Polk & Wardwell advised the representative of the several initial purchasers. MicroStrategy...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Viridian Therapeutics, Inc. in the offering, and Wilmer Cutler Pickering Hale and Dorr represented the underwriters. Viridian Therapeutics, Inc. (Nasdaq: VRDN), a...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr and Cooley advised on Terns Pharmaceuticals, Inc. on the offering, and Davis Polk & Wardwell advised the underwriters. Terns Pharmaceuticals,...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented the underwriters. Kymera Therapeutics, Inc. (Nasdaq: KYMR) (Kymera), a clinical-stage biopharmaceutical company, announced its public offering of 2,830,533 shares...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented MicroStrategy Incorporated in the offering. MicroStrategy® Incorporated (Nasdaq: MSTR) (“MicroStrategy”) announced that it has completed its offering of 2.25%...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Disc Medicine, Inc. on the offering, and Wilmer Cutler Pickering Hale and Dorr advised the underwriter. Disc Medicine, Inc. (Nasdaq: IRON) (“Disc”) announced...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt acted as Canadian counsel to Milestone Pharmaceuticals Inc. in the offering, Cooleyacted as US counsel to the company. Wilmer Cutler Pickering Hale...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented MicroStrategy® Incorporated in the offering, and Davis Polk & Wardwell advised the representative of the initial purchasers. MicroStrategy Incorporated...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented TechTarget, Inc. in the transaction, and Clifford Chance represented Informa PLC. TechTarget, Inc. (NASDAQ: TTGT) and Informa PLC (LSE:...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Kymera Therapeutics, Inc. on the offering, and Wilmer Cutler Pickering Hale and Dorr advised the underwriters. Kymera Therapeutics, Inc. (Nasdaq: KYMR) (“Kymera”) announced its...
You must be a Standard 1 Year member to access this content.
